Research programme: replacement therapeutics - GlycomineAlternative Names: M1P; Mannose-1-phosphate; Recombinant human N-glycanase 1; rhNgly1
Latest Information Update: 30 Nov 2016
At a glance
- Originator Glycomine
- Class Enzymes; Sugar phosphates
- Mechanism of Action Enzyme replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inborn error metabolic disorders